Busulfan therapy for chronic myelogenous leukemia can cause fatal pulmonary fibrosis, known as "busulfan lung." This report details the first pediatric case in a 16-month-old infant, highlighting the drug
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: